Company intelligence / Profile preview

Dandu Biosciences

Hyderabad, Telangana, Indiadandubio.com ↗
Ownership
Private
Employees
~75
Development stage
Preclinical
01

Overview

Dandu Biosciences is a Hyderabad-based biotech company focused on developing and manufacturing biosimilars and complex generic pharmaceuticals, aiming to provide affordable medications globally. Their portfolio includes at least one key product, Liraglutide, but no detailed clinical results or approvals are publicly available as of the latest updates.

Therapeutic areas
Endocrinology
Modalities
BiosimilarsComplex generics
Industry
Biotech
02

Drug pipeline

2 assets

Invertase Peptide

Preclinical

1 more asset in the full pipeline.

Beyond the preview

Go deeper on Dandu Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dandu Biosciences.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call